Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
Amir Hosseini1, Håvard T Lindholm2, Raymond Chen3
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
Abstract:
Viral mimicry describes the immune response induced by endogenous stimuli such as double-stranded RNA (dsRNA) from endogenous retroelements. Activation of viral mimicry has the potential to kill cancer cells or augment anti-tumor immune responses. Here, we systematically identify mechanisms of viral mimicry adaptation associated with cancer cell dependencies. Among the top hits is the RNA decay protein XRN1 as an essential gene for the survival of a subset of cancer cell lines. XRN1 dependency is mediated by mitochondrial antiviral signaling protein and protein kinase R activation and is associated with higher levels of cytosolic dsRNA, higher levels of a subset of Alus capable of forming dsRNA, and higher interferon-stimulated gene expression, indicating that cells die due to induction of viral mimicry. Furthermore, dsRNA-inducing drugs such as 5-aza-2'-deoxycytidine and palbociclib can generate a synthetic dependency on XRN1 in cells initially resistant to XRN1 knockout. These results indicate that XRN1 is a promising target for future cancer therapeutics.
Insights
Viral mimicry, triggered by endogenous double-stranded RNA (dsRNA), can be exploited to target cancer. Researchers found the RNA decay protein XRN1 is essential for survival in some cancer cells, suggesting it as a therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Viral mimicry involves immune responses to endogenous stimuli like double-stranded RNA (dsRNA).
- Activating viral mimicry shows potential for cancer cell death and enhanced anti-tumor immunity.
Purpose of the Study:
- To systematically identify mechanisms of viral mimicry adaptation linked to cancer cell dependencies.
- To explore the role of the RNA decay protein XRN1 in cancer cell survival and viral mimicry.
Main Methods:
- Systematic identification of cancer cell dependencies related to viral mimicry.
- Analysis of XRN1 dependency, mitochondrial antiviral signaling (MAVS), and protein kinase R (PKR) activation.
- Quantification of cytosolic dsRNA, Alu elements, and interferon-stimulated gene expression.
- Investigating the effects of dsRNA-inducing drugs (5-aza-2'-deoxycytidine, palbociclib) on XRN1 dependency.
Main Results:
- XRN1 was identified as an essential gene for the survival of a subset of cancer cell lines.
- XRN1 dependency is linked to MAVS and PKR activation, increased cytosolic dsRNA, and elevated interferon-stimulated gene expression.
- Cancer cells exhibiting these characteristics die due to induced viral mimicry.
- dsRNA-inducing drugs created a synthetic dependency on XRN1 in resistant cancer cells.
Conclusions:
- XRN1 is crucial for cancer cell survival under conditions of induced viral mimicry.
- The interplay between XRN1, dsRNA, and innate immune signaling pathways is key to this dependency.
- Targeting XRN1, potentially in combination with dsRNA-inducing agents, represents a promising therapeutic strategy for cancer treatment.
More Related Videos
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Non-LTR Retrotransposons
Retroviruses
Retrovirus Life Cycles
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Restarting Stalled Replication Forks


